“Diabetic ulcers are the number one non-traumatic cause of lower limb amputations worldwide,” said Ameer. “Sometimes it might ...

Researchers have developed the first wearable device for measuring gases emitted from and absorbed by the skin, allowing for ...

As part of the transition to the new administration, CMS is reviewing its coverage policies for skin substitute products.

Celularity (CELU) welcomes action by the Centers for Medicare & Medicaid Services, or CMS, to revise to January 1, 2026, the effective date ...

CMS issued the following statement on Local Coverage Determination for certain skin substitute grafts: “As part of the transition to a new ...